SCHEMBL1294833

SCHEMBL1294833

CCOC(=O)CC(c1ccccc1)n1c(=O)[nH]c2ccc(C#N)nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.40
▸ HTT P42858 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ USP1 O94782 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 3/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ PAK4 O96013 1/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ LCK P06239 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ RET P07949 1/20 0.35
▸ MET P08581 1/20 0.35
▸ PDGFRB P09619 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1294827 1.00 KDM4E (0.40) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294811 0.87 KDM4E (0.44) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294810 0.87 KDM4E (0.44) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL12104664 0.85 KDM4E (0.47) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294511 0.84 KDM4E (0.42) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294514 0.84 KDM4E (0.42) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1295165 0.81 KDM4E (0.44) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1295168 0.81 KDM4E (0.44) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294706 0.77 USP1 (0.46) KDM4EHTTALDH1A1USP1MAPT
SCHEMBL1294710 0.77 USP1 (0.46) KDM4EHTTALDH1A1USP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062056-B2 Aza-benzimidazolone Chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-06-23 — — US disclosed
EP-2364313-B1 AZA-BENZIMIDAZOLONE CHYMASE INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2014-01-08 — — EP disclosed
US-20110269780-A1 AZA-BENZIMIDAZOLONE CHYMASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269780-A1 AZA-BENZIMIDAZOLONE CHYMASE INHIBITORS CMA1, CPA3, SERPINB1 KDM4E 763/4885HTT 4167/4885ALDH1A1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback